{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-008904","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.659049+00:00","generated_at":"2026-05-16T11:03:58.087357+00:00","sec_items":["5.03","7.01","8.01","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Athira Pharma renames to LeonaBio (LONA); lasofoxifene Phase 3 >50% enrolled; CFO gets new severance","bullets":["Name change to LeonaBio effective Jan 9, 2026; ticker to LONA on Nasdaq starting Jan 12.","Phase 3 ELAINE-3 trial of lasofoxifene >50% enrolled; topline data expected mid-2027.","CFO Robert Renninger entered amended change in control severance agreement; base salary increased to $460,000.","Name change reflects Dec 2025 acquisition of lasofoxifene rights, with $90M upfront financing and potential additional $146M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-008904","json":"https://secwatch.observer/filing/0001193125-26-008904.json","markdown":"https://secwatch.observer/filing/0001193125-26-008904.md","text":"https://secwatch.observer/filing/0001193125-26-008904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/atha-20260107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:03:58.087357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"312235b1bf84c3e1e05e8ef2a22d0f7858c6b515","claim":"LeonaBio, Inc.: Certificate of Amendment to Amended and Restated Certificate of Incorporation to change corporate name from Athira Pharma, Inc. to LeonaBio, Inc (effective 2026-01-09).","evidence_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","confidence":0.9},{"claim_id":"69eae61f6a6e9483c12cc498b59fe6d70dee29ad","claim":"LeonaBio, Inc.: Amended and restated bylaws to reflect the name change to LeonaBio, Inc (effective 2026-01-09).","evidence_excerpt":"Additionally, effective January 9, 2026, the Board approved an amendment and restatement of the Company’s bylaws (the “Amended and Restated Bylaws”) to reflect the Name Change.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-061109","ticker":"BRKH","company_name":"BurTech Acquisition Corp II","filed_at":"2026-05-26T21:20:22+00:00","headline":"Burtech Acquisition Corp II closes $80M IPO; units begin trading on Nasdaq","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061109","json":"https://secwatch.observer/filing/0001213900-26-061109.json","markdown":"https://secwatch.observer/filing/0001213900-26-061109.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2098707/000121390026061109/0001213900-26-061109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2098707/000121390026061109/ea0292100-8k_burtech2.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 21, 2026, and in connection with the IPO, the Company adopted and filed its Amended and Restated Memorandum and Articles of Association.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2098707/000121390026061109/0001213900-26-061109-index.htm"}},{"accession":"0000943374-26-000219","ticker":"DCOM","company_name":"Dime Community Bancshares, Inc. /NY/","filed_at":"2026-06-01T20:02:33+00:00","headline":"Dime Commercial Bancshares name change effective; three executives amend employment agreements","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000219","json":"https://secwatch.observer/filing/0000943374-26-000219.json","markdown":"https://secwatch.observer/filing/0000943374-26-000219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/form8k_052826.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"Subsequent to the approval by its shareholders at the Extension Meeting of Rising Dragon’s second amended and restated memorandum and articles of association (the “Amended Charter”), the Company filed the Amended Charter with the Cayman Islands Registrar of Companies, effective May 28, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm"}},{"accession":"0001213900-26-061794","ticker":"DAIC","company_name":"CID Holdco, Inc.","filed_at":"2026-05-28T12:35:20+00:00","headline":"CID HoldCo (Dot Ai) implements 1-for-25 reverse stock split effective May 29, 2026","event_type":"other_material","sec_items":["3.03","5.03","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-061794","json":"https://secwatch.observer/filing/0001213900-26-061794.json","markdown":"https://secwatch.observer/filing/0001213900-26-061794.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/0001213900-26-061794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/ea0292442-8k_cidhold.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The information set forth in Item 3.03 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 5.03. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2033770/000121390026061794/0001213900-26-061794-index.htm"}},{"accession":"0001193125-26-240338","ticker":"LUMN","company_name":"Lumen Technologies, Inc.","filed_at":"2026-05-27T10:02:11+00:00","headline":"Lumen shareholders approve 45.6M share increase to equity plan, eliminate supermajority votes","event_type":"other_material","sec_items":["5.02","5.07","5.03","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-240338","json":"https://secwatch.observer/filing/0001193125-26-240338.json","markdown":"https://secwatch.observer/filing/0001193125-26-240338.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/18926/000119312526240338/0001193125-26-240338-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/18926/000119312526240338/d115129d8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 20, 2026, at the Annual Meeting, the shareholders of the Company approved amendments to the Company’s Articles of Incorporation, as amended, to: • eliminate certain of the supermajority voting requirements for matters subject to shareholder approval and to replace such requirements with a majority of votes cast standard; and • exclude certain categories of persons from the definition of “Related Person”. On May 26, 2026, the Company filed Amended and Restated Articles of Incorporation reflecting the foregoing amendments","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/18926/000119312526240338/0001193125-26-240338-index.htm"}},{"accession":"0001628280-26-038220","ticker":"DTIL","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2026-05-26T21:20:29+00:00","headline":"Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-038220","json":"https://secwatch.observer/filing/0001628280-26-038220.json","markdown":"https://secwatch.observer/filing/0001628280-26-038220.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/dtil-20260521.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 22, 2026, the Company filed the 2026 Amendment with the Secretary of State of the State of Delaware, and the 2026 Amendment became effective upon filing.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm"}},{"accession":"0001104659-26-066316","ticker":"OMCL","company_name":"OMNICELL, INC.","filed_at":"2026-05-26T20:40:24+00:00","headline":"Omnicell shareholders approve 1.6M share increase to equity plan and officer exculpation amendment","event_type":"other_material","sec_items":["5.02","5.07","5.03","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.02, 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066316","json":"https://secwatch.observer/filing/0001104659-26-066316.json","markdown":"https://secwatch.observer/filing/0001104659-26-066316.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/926326/000110465926066316/0001104659-26-066316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926326/000110465926066316/tm2615515d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"Effective January 9, 2026, Athira Pharma, Inc. (the “Company”) changed its name to LeonaBio, Inc. (the “Name Change”). The Name Change was approved by the Company’s Board of Directors (the “Board”) and was effectuated through the filing of a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526008904/0001193125-26-008904-index.htm","comparable_excerpt":"On May 20, 2026, the Company amended the Company’s Amended and Restated Certificate of Incorporation to provide exculpation from personal liability for certain officers as permitted by Delaware law and make certain other minor, non-substantive updates","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/926326/000110465926066316/0001104659-26-066316-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}